News
Patients running out of options, antibiotics not working against infections – WHO
World Health Organisation has said patients are running out of options as antibiotics stop working against infections, warning that the situation today is worse than it was in 2019.
WHO, in a statement on Wednesday stated that the common bacteria were becoming highly resistant to front-line and even “last-resort” antibiotics. It gave the warning on the sidelines of World Antimicrobial Resistance Awareness Week.
WAAW is a global campaign to raise awareness and increase understanding of antimicrobial resistance and to promote global action to tackle the emergence and spread of drug-resistant infections.
WAAW is observed annually from November 18 to 24.
The UN health agency issued the alert with the European Centre for Disease Prevention and Control after analysing progress on targets to reduce infections caused by resistant bacteria—often described as “superbugs”—that thrive in healthcare settings.
Instead of achieving the target of a five per cent fall in infections from the common hospital bacterium Klebsiella pneumoniae, they rose by an estimated 72 per cent between 2019 and 2025.
And infections with E. coli bacterium—which are also resistant to regular antibiotics known as cephalosporins—were set a target of a 10 per cent decrease. Instead, they rose by more than 16 per cent.
WHO said that it found resistance to key antibiotics in at least half of the samples of Klebsiella pneumoniae and another common bug, Acinetobacter, in about one in two countries in Europe.
Marc-Alain Widdowson, head of health security at WHO/Europe said that in many countries in the region, “the antibiotics doctors usually reach for first are failing against serious hospital infections”.
When these treatments fail to work, doctors turn to stronger drugs normally kept for the most serious cases that are called carbapenems.
“When those stop working too, what’s left is mostly a small group of last-resort drugs that are often expensive and not available in every country,” he explained. “Each time one of these lines of defence falls, patients move closer to having no good options at all. That matters, because people whose first antibiotic doesn’t work against their infection are more likely to die in hospital.”
WHO noted that of 51 countries analysed, 16 still lack a standardized national approach and national coordination, hampering the effort to overcome antimicrobial resistance globally.
In hospitals where few blood samples are taken to identify the bacteria behind an infection, doctors often “have to choose an antibiotic without knowing which will work”, the agency said.
For patients, this raises the risk of starting treatment on a drug that will not work. And for health systems, “it means planning half-blind”, WHO stressed, since without reliable data, countries cannot tell where resistance is spreading or whether their efforts to stop it are working.
“Better testing would help on both fronts, giving patients the right drug sooner and countries a clearer view of the threat,” said Mr Widdowson.
In more positive news, the estimated rate of bloodstream infections caused by resistant Acinetobacter has almost halved since the high levels seen in 2021 during the COVID-19 pandemic.
(NAN)
-
African News21 hours agoSouth Africans Demand Total Ban On Nigerians In Fresh Protest
-
News20 hours agoBREAKING: Court restrains Jimmy Odukoya from parading himself as senior pastor of Fountain of Life Church
-
Metro20 hours agoMan accused of AI cheating in South Korean exam found dead
-
Business15 hours agoFidelity Bank appoints Stanley Amuchie as new CEO
-
Business19 hours agoInside Nigeria’s trillion-naira pipeline security system where oil theft persists
-
Business8 hours agoNaira slides to N1440/$ as foreign reserves shed $406m
-
Business8 hours agoKola Karim’s $10bn ambition: Building Nigeria’s answer to Tata
-
News20 hours agoTinubu confers GCON on Wole Olanipekun
